Grossman Adam S bought ADMA
March 16, 2026 · Form 4 insider transaction
Grossman Adam S bought 15,000 shares of ADMA Biologics, Inc. at $5.40 per share, a transaction worth $81.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$5.40
Total value
$81.0K
InsiderGrossman Adam S
RoleOfficer, Director
CompanyADMA Biologics, Inc. (ADMA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 16, 2026
Filing dateMarch 17, 2026
Shares owned after2,133,777
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025.